MOTION: ?

"That Senate approve, for a three year period,

the admission of students who are selected

for entry to the Institute of Canadian Bankers

Program who have not otherwise met normal

admission requirements, provided they are

registering in that program and will under-

i

stake approved courses at this institution."

0

---

The Institute of Canadian Bankers for a number of years has had

in existence programs leading to the ICB Certificate. Discussions

have been under way for some time with the Institute concerning

desires to utilize a number of regular Senate approved courses of

this institution in fulfilment of part of the full ICB Program.

Students registered in the ICB Program undertaking the regular

approved courses at Simon Fraser University may be exempted up to

six

full year courses of the twelve required to complete the full

ICB Program. Such exemption would be a matter for ICB and not

fall under University jurisdiction.

Students in the ICB Program would register for credit, but during

the initial three year period would be permitted to convert to

audit at the end of the ninth week of classes in a course, but

without any fee adjustment.

The majority of persons selected for entry to the ICB Program will

have fulfilled Simon Fraser University admission requirements in

the normal fashion or through mature student regulations. Some of

the individuals selected for entry by the Institute in the past

may not have fulfilled these requirements. It is expected that

there may continue to be some such persons in the future who would

fall in this category.

MOTION

That Senate approve, for a three year period, the

admission of students who are selected for entry

to the Institute of Canadian Bankers Program who

have not otherwise met normal admission require-

ments, provided they are registering in that

program and will undertake approved courses at

this institution.

Note: It is the intention to review the progress of persons so

admitted in the three year period proposed to make appro-

priate recommendations at the end of this trial period.

0